Maastricht, April 9, 2021 – Today the Dutch cabinet decided to fully fund the National Growth Fund application of RegMed XB. A maximum of 56 million euros will be available for setting up a pilot plant for regenerative medicine.

Last Thursday 11 and Friday 12 March 2021, RegMed XB’s first online Townhall Event took place instead of the planned Annual Meeting.

Scinus Cell Expansion BV, a RegMed XB partner, has made the next step in bringing solutions to patients. Prometheus at KU Leuven, Belgium, installed a novel bioreactor from Scinus Cell Expansion B.V.